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ABSTRACT 
Introduction:  
Multicystic dysplastic kidney (MCDK) disease is a common non-inherited developmental 
anomaly, increasingly diagnosed antenatally. It is a single functional kidney associated with 
increased risk of anomaly of the opposite kidney.   
Methods:  
A retrospective descriptive study of paediatric patients with MCDK disease was undertaken at a 
secondary-tertiary level hospital from January 1986 to December 2015. 
Results:  
Over a 30 year period, 59 patients were identified; 36 (59%) were male and 31 (52.5%) were left 
sided. Overall, 20 (33.9%) of cases were diagnosed antenatally, with an increased frequency of 
cases diagnosed in the last decade (p=0.015).  Eight (13.6%) had associated contralateral 
abnormalities; none had reflux into contralateral kidney. 
Conclusion:  
The number of MCDK diagnosed was low but increasing, due to increased antenatal sonars in the 
last decade. None of the patients had reflux into the contralateral kidney. The patients (only study 
from Africa) showed similar demographics to the rest of the studies on MCDK. 
  
v 
 
ACKNOWLEDGEMENTS 
I acknowledge the following people: 
Prof UK Kala my supervisor and mentor. 
Dr Ziyaad Dangor who helped with statistics and helped nudge me on.  
Prof Sanjay Lala whose friendship and insightful thoughts have helped me with my 
research.  
Dr Brijesh Lala, my brother, with general help.  
Finally I’d like to acknowledge Mrs Sandra Benn, she motivated me more than she will 
know. 
  
  
vi 
 
Table of Contents 
DECLARATION ............................................................................................................................. ii 
DEDICATION ............................................................................................................................... iii 
ABSTRACT ................................................................................................................................... iv 
ACKNOWLEDGEMENTS ............................................................................................................ v 
LIST OF FIGURES ...................................................................................................................... viii 
LIST OF TABLES ......................................................................................................................... ix 
ABBREVIATIONS ......................................................................................................................... x 
1.0 Introduction .......................................................................................................................... 1 
1.1 Epidemiology .................................................................................................................... 1 
1.2 Diagnosis and clinical presentation of MCDK ................................................................. 2 
1.3 Management of MCDK .................................................................................................... 3 
1.4 Prognosis of MCDK ......................................................................................................... 4 
1.5 Our experience at CHBAH (Chris Hani Baragwanath Academic Hospital) .................... 4 
2.0 Objectives ............................................................................................................................. 5 
3.0 Methods ................................................................................................................................ 5 
3.1 Study Design ..................................................................................................................... 5 
3.2 Study population ............................................................................................................... 5 
3.3 Study Method .................................................................................................................... 5 
3.4 Sample Size Calculation ................................................................................................... 6 
3.5 Data Analysis .................................................................................................................... 6 
4.0 Results .................................................................................................................................. 7 
4.1 Demographic data ............................................................................................................. 7 
4.2 Clinical Parameters ......................................................................................................... 11 
4.3 Urinary tract infection ..................................................................................................... 12 
4.4  Radiological investigations ............................................................................................. 12 
4.5 Renal surgical interventions ............................................................................................ 14 
4.6 Glomerular filtration rate ................................................................................................ 14 
4.7 Outcomes ........................................................................................................................ 15 
4.8 Changes in antenatal presentation over study period ...................................................... 17 
5.0 Discussion ........................................................................................................................... 18 
6.0 Conclusion .......................................................................................................................... 26 
vii 
 
7.0 Recommendations .............................................................................................................. 28 
8.0 References .......................................................................................................................... 29 
9.0 Appendices ......................................................................................................................... 33 
 
viii 
 
LIST OF FIGURES 
 
  Page 
Figure 1.1: Schematic representation of a normal (left) and a 
multicystic dysplastic kidney (MCDK). 
 
1 
Figure 1.2: Mercaptoacetoacetyltriglycine (Mag3) scan of one of our 
patients 
 
3 
Figure 4.1: Box and whisker plot for weight, height and BMI at 
admission and last visit 
 
10 
Figure 4.2: Flow diagram showing the outcome of patients with MCDK 
stratified by simple and complex MCDK  
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ix 
 
LIST OF TABLES 
  Page 
Table 4.1: Demographic characteristics of patients stratified by simple and complex 
Multicystic Dysplastic Kidney (MCDK) disease 
 
8 
Table 4.2: Age stratification at diagnosis  
 
9 
Table 4.3: Opposite kidney abnormality of patients stratified by simple and complex 
Multicystic Dysplastic Kidney (MCDK) disease 
 
9 
Table 4.4: Cultured organisms in children with a urinary tract infection (UTI) 
stratified by simple and complex Multicystic Dysplastic Kidney (MCDK) 
disease 
 
12 
Table 4.5: Frequency of radiological investigations of patients stratified by simple and 
complex Multicystic Dysplastic Kidney (MCDK) disease  
 
13 
Table 4.6: Renal surgery of patients stratified by simple and complex Multicystic 
Dysplastic Kidney (MCDK) disease  
 
14 
Table 4.7: Glomerular filtration rate (GFR) at admission, last visit and last calculable 
value 
 
14 
Table 4.8: Outcomes of patients with simple and complex Multicystic Dysplastic 
Kidney (MCDK) disease 
 
15 
Table 4.9: Proportion of patients diagnosed on antenatal ultrasound over three decades  
 
17 
 
 
  
x 
 
ABBREVIATIONS 
 
AKI                 Acute Kidney Injury 
BMI                 Body mass index 
BP                   Blood Pressure 
CAT                Computerised Axial Tomography 
CHBAH Chris Hani Baragwanath Academic Hospital 
CKD  Chronic Kidney Disease 
DMSA             Dimercaptosuccinic Acid  
DTPA              Diethylenetriaminepentacetate  
GFR                 Glomerular Filtration Rate 
eGFR               estimated Glomerular Filtration Rate  
ESRD              End Stage Renal Disease 
HAZ                Height/length for age z score 
HIV             Human Immunodeficiency Virus 
IQR                 Interquartile Range 
IVP                  Intravenous pyelogram 
Mag3               Mercaptoacetoacetyltriglycine scan 
MCDK            Multicystic Dysplastic Kidney 
MRU               Magnetic Resonance Urography 
PUJ  Posterior Urethral Junction 
PUV  Posterior Urethral Valves 
UTI  Urinary Tract Infection 
VCU  Voiding Cystourethrogram 
VUJ  Vesicoureteral Junction 
xi 
 
VUR  Vesicoureteral Reflux  
WAZ              Weight for age z score
1 
 
1.0 Introduction 
1.1 Epidemiology  
Multicystic dysplastic kidney disease (MCDK) is defined as a non-inherited developmental 
anomaly of the kidney. It is characterised by multiple non-communicating cysts of varying sizes 
and no identifiable renal parenchymal tissue (1, 2). See Figure 1.1. It was first described by 
Cruveilhier in 1836 (3). MCDK is a common congenital anomaly with incidences ranging from 1 
in 1000 to 1 in 4300 live births in developed countries (1, 4).  
 
The aetiology is unknown, but is generally attributed to one of two embryological theories. The 
first theory postulates that there is atresia of the pelvic ureter, at the pelvic-ureteric junction, 
which results in severe urinary obstruction, hydronephrosis and development of MCDK (5). The 
second theory postulates an abnormal interaction between the ureteric bud and metanephric 
blastema resulting in failure of differentiation of the normal anatomical structures (6).  Other 
theories include intra-uterine infection and drug exposures (7).   
 
 
Figure 1.1: Schematic representation of a normal (left) and a multicystic dysplastic kidney 
(MCDK).Sketch drawn by Aarti Lala 
Normal Kidney 
MCDK  
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1.2 Diagnosis and clinical presentation of MCDK 
In developed countries the diagnosis is made on antenatal ultrasound screening (60-80%) in the 
majority of the patients (1, 5). Fewer cases are diagnosed antenatally in developing countries due 
to limited resources (8). MCDK patients are usually asymptomatic in childhood and therefore the 
diagnosis may be missed. Some cases are detected due to the presence of an abdominal mass, 
investigation of urinary tract infections (UTI) or an incidental finding on renal imaging (4).  
 
Patients with MCDK will generally have a single functional kidney. The functional kidney can be 
associated with an increased risk of anomalies namely vesicoureteral reflux (VUR) obstruction in 
7-26%, posterior urethral valves (PUV) in 1.5-5%  and vesicoureteral junction (VUJ) obstruction 
in 2% (9). 
 
Ureterocoeles, horseshoe kidney and undescended testis have also been occasionally described 
(9).  Patients’ with anomalies of the functional kidney have been found to have poorer outcomes. 
Thus numbers of authors have classified it into simple and complex MCDK (2, 10, 11). Therefore 
early diagnosis, further laboratory and radiological investigation of the single kidney are 
necessary. Bilateral MCDK have been described and present as Potter’s sequence but do not 
survive in the absence of renal replacement therapy; kidney transplant or dialysis (12).  
 
The natural history of MCDK is generally benign unless the single kidney is functionally 
abnormal. The MCDK either involutes in 35-63% or decreases in size in 30-44% (1). Generally, 
by the age of 15 years, the contralateral kidney hypertrophies in 95% of cases (5). There is debate 
as to whether MCDK increases or decreases the risk of hypertension (13). Nevertheless, BP 
(Blood Pressure) monitoring is essential in these cases. Although MCDK was thought to increase 
the risk of malignant transformation, this has not been proven (14). Thus the surgical removal of 
the kidney is not warranted unless other indications, such as recurrent UTI’s and/or uncontrolled 
hypertension are present(7). Mortality is attributed to bilateral MCDK and the morbidity is due to 
long-term nephrological sequelae (9). Minimal data has been reported from developing countries 
and currently no data is available from Africa. Complications associated with MCDK with or 
without an evidence base include Wilms Tumour, hypertension, CKD (Chronic Kidney Disease) / 
ESRD (End Stage Renal Disease), UTI and VUR (10), as well as chronic hyperfiltration injury 
(15).  
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1.3 Management of MCDK 
The standard of care for investigating MCDK includes an ultrasound examination of the kidneys 
and radionuclear scan to confirm the non-functionality of the kidney. See Figure 1.2 below which 
shows a Mag3 scan with no uptake in anatomical area of right kidney. The scan is taken 
posteriorly. In the past voiding cystourethrogram (VCU) was routinely used to exclude VUR. 
Recent data suggest that VCU offers little benefit (16). These imaging modalities are also used to 
confirm contralateral anomalies which may be correctable surgically.  These recommendations 
might not be appropriate within a limited resource setting where the availability and quality of 
radiological imaging, including ultrasound, is limited. Whether this finding in our setting is 
consistent with that of other studies is not known. Most studies have thus far shown reasonable 
consistency in the natural progression and findings of MCDK patients. 
 
 
 
 
Figure 1.2: Mercaptoacetoacetyltriglycine (Mag3) scan of one of our patients. Showing lack of 
tracer uptake in area of right kidney 
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 1.4 Prognosis of MCDK 
The risk for chronic kidney disease (CKD) is negligent in MCDK but increases if the 
contralateral kidney has an abnormality (15). Generally MCDK has a favourable outcome.  
  
1.5 Our experience at CHBAH (Chris Hani Baragwanath Academic Hospital) 
Children presenting with kidney disease are referred to paediatric nephrology for investigation 
and management. The department of nephrology at the CHBAH was established in the late 
1970’s. To our knowledge, there is no data on the burden, clinical, laboratory or radiological 
presentation of MCKD in Africa. The aim of this long-term retrospective review is to describe 
the epidemiology of MCKD in a resource limited setting where antenatal diagnostic ultrasounds 
are limited. The data was obtained from the paediatric renal clinic at CHBAH to complete the 
study. 
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2.0 Objectives  
2.1 To describe the clinical, laboratory and radiological characteristics of MCDK in 
children less than 15 years of age at the CHBAH. 
2.2 To determine the outcomes of children with MCDK. 
2.3 To determine the rate of lost to follow-up in children with MCDK 
3.0 Methods 
3.1 Study Design 
This was a retrospective descriptive study. Case records of children less than 15 years of age with 
MCDK disease who were seen at CHBAH from January 1986 to December 2015 were reviewed.  
 
3.2 Study population 
CHBAH is the only government funded tertiary paediatric hospital to the residents of Soweto and 
surrounding areas. In addition, the hospital’s catchment area for complicated renal pathology 
extends into other provinces, especially North West Province, and part of the neighbouring 
countries. Soweto is a peri-urban black-African community, situated south of Johannesburg, and 
has a large number of migrants living in informal settlements. Most residents are from lower 
socio-economic backgrounds and approximately 45% are unemployed (17). Most residents of 
Soweto are thus forced to utilise free government health care services.  
 
3.3 Study Method 
Children diagnosed with MCKD at CHBAH over the last 30 years have clinical and 
laboratory/radiological records stored in the department of paediatric nephrology. These files are 
clearly labelled and easily accessible to retrieve patient records. All files marked with a diagnosis 
of MCKD were retrieved. Clinical, laboratory and radiological information was collected and 
entered onto a specifically designed data collection sheet, documenting demographic information, 
the clinical presentation and patient outcomes, at baseline and at subsequent visits. The sex, age 
of presentation, presenting complaints, side of the MCDK, referral hospital, opposite kidney 
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abnormality and surgical interventions were recorded. MCDK were separated into two groups, 
simple and complex MCDK. Simple MCDK was defined as a unilateral dysplasia and normal 
contralateral kidney and complex MCDK was defined as bilateral dysplasia or abnormality of 
contralateral kidney (2, 10). A urine-dipsticks result from each visit was documented. Blood 
markers such were obtained from patient records and GFR (Glomerular Filtration Rate) 
calculated. Available ultrasound, voiding cysto-urethrogram and radio-nucleotide scan findings 
were recorded. 
3.4 Sample Size Calculation 
As this is a long-term descriptive retrospective study, no sample calculation was done.  
3.5 Data Analysis 
Data from study-specific data collection forms were entered into a specially designed database. 
Demographic and clinical findings which include laboratory and radiological characteristics was 
reported. Continuous variables were reported using means or medians depending on the 
distribution of the data. Categorical variables were reported as proportions. Clinical, laboratory 
and radiological data was compared at baseline to subsequent visits using the Student t-test, 
Pearson chi-squared or Fischer’s exact test. 95% confidence intervals and p<0.05 was considered 
to be statistically significant. Data has been analysed using STATA version 13.1 (College 
Station, Texas, USA).  
 
This study has been approved by the Human Research Ethics Committee of the University of 
Witwatersrand (M161027). 
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4.0   Results 
4.1 Demographic data 
Characteristics of the patients over the thirty year period were noted. The median age of 
presentation was 19 days with an IQR (Interquartile Range) of six to 121 days. The patients were 
divided in two groups. The first group were patients that had simple MCDK and the second group 
had complex MCDK. The median age of presentation was 19 days (IQR six to 191 days) in the 
simple MCDK and 17 days in complex MCDK (IQR nine to 34 days). 
  
The total numbers of patients were 59. Of these only eight (13.6%) patients were complex 
MCDK. Seven (11.9%) patients had PUJ (Posterior Urethral Junction) obstruction on the 
opposite side. Three of these patients needed pyeloplasty. One (1.7%) patient had a ureteric 
stricture and was treated conservatively. 
 
 
There were an increased number of males compared to females. In total there were 36 (61.0%) 
males and 23 (49.0%) females. The simple MCDK had 30 (55.8%) males whereas the complex 
MCDK had six (75.0%) males. These values were not found to be statistically significantly 
different in the two groups.  
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Table 4.1: Demographic characteristics of patients stratified by simple and complex Multicystic 
Dysplastic Kidney (MCDK) disease 
Characteristics 
Overall 
n=59 (%) 
Simple 
n=51 (%) 
Complex 
n=8 (%) 
p-value
1
 
Gender 
    Male 36 (61.0) 30 (55.8) 6 (75.0) 0.464 
Age (days) at presentation     
Median (IQR) 19 (6-121) 19 (6-191) 17 (9-34) 0.698 
Side of MCDK     
Right 28 (47.5) 23 (45.1) 5 (62.5) 
0.458 
Left 31 (52.5) 28 (54.9) 3 (37.5) 
Presenting complaint
2
     
Antenatal ultrasound 11 10 1 
0.564 
Abdominal mass 29 23 6 
Antenatal ultrasound and mass 9 9 0 
Urinary tract infection 7 6 1 
Acute kidney injury 2 2 0 
Incidental cardiac 
catheterization finding 
1 1 0 
Incidental ultrasound finding 6 6 0 
Referral Other hospital 20 (33.9) 15 (29.4) 5 (62.5) 0.106 
1
p-value - using the chi-squared, Fishers exact or Mann Whitney test,
 2
Patients may have had 
more than one presenting complaint  
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Table 4.2: Age stratification at diagnosis 
Age Number (n=59) Percentage 
Prenatal 20 33.9 
<1 month 15 25.4 
1 month to 1 year 18 30.5 
>1 year 6 10.2 
 
 
Table 4.3: Opposite kidney abnormality of patients stratified by simple and complex Multicystic 
Dysplastic Kidney (MCDK) disease 
Opposite Kidney Abnormality 
Overall 
n=59 (%) 
Simple 
n=51 (%) 
Complex 
n=8 (%) 
p-value
1
 
PUJ
3
 obstruction 7 (11.9) 0 7 (87.5) 
- 
Ureteric stricture 1 (1.7) 0 1 (12.5) 
VCU
4
  n=43 n=35 n=8  
Reflux into MCDK 1 (2.3) 0 1 (12.5) 
0.186 
Normal 42 (97.7) 35 (100) 7 (87.5) 
3
PUJ- Posterior Urethral Junction, 4VCU- Voiding Cystourethrogram 
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The weight, height/length and BMI (Body Mass Index) at presentation and at the last visit are 
shown in the Figure 4.1 below. No significant differences in weight for age, length/height for age 
and BMI for age were observed in children with MCDK when comparing these parameters 
between presentation and at the last visit. 
 
 
Figure 4.1: Box and whisker plot for weight, height and BMI at admission and last visit 
Footnote: WAZ A/L-Weight for age z score at admission/last visit, HAZ A/L - Height/length for 
age z score at admission/last visit, BMI A/L - Body mass index for age z score at admission/last 
visit 
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4.2 Clinical Parameters 
The presenting complaints varied. The majority of the patients presented with an abdominal mass 
(49%) 29 of total patients (Table 4.1). Antenatal ultrasound diagnosis of MCKD was made in 11 
(18.6%) patients; a further nine patients were, in addition to presenting with a mass, also found to 
have  been diagnosed on antenatal ultrasound making it a total of 33.9%. UTI was found in seven 
patients at presentation. However 11 patients grew organisms on urine culture. Two patients 
presented with AKI (Acute Kidney Injury). One patient was referred from cardiology after a 
cardiac catheterisation study showing lack of uptake of contrast during the study. Six patients 
were found to have MCDK incidentally during an ultrasound study. These characteristics were 
not compared between the two groups because some had multiple presentations. Some patients 
presented with more than one complaint and hence a statistical analysis was not done between the 
simple and complex MCDK groups. 
 
Twenty of the patients were referred to our hospital from outside of Soweto. Although not 
statistically significant a higher percentage of the complex MCDK (62.5%) were referred 
compared to the simple MCDK (29.4%). None of our patients tested for HIV (Human 
Immunodeficiency Virus) were found to be positive. However 29 patients (49.2%) were not 
tested.  
 
The left sided MCDK was found be more common in both groups. Left sided simple MCDK was 
observed in 52.5% of the patients and left sided complex MCDK was observed in 54.9% of the 
patients. In our patients over the 30 years only four patients had nephrectomies done. One had the 
nephrectomy together with a pyeloplasty.  
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4.3 Urinary tract infection 
At presentation 11 patients were shown to have proven urinary tract infections. Eight patients had 
Escherichia coli, two of which had complex MCDK. Two patients had Klebsiella species and one 
had a Candida species.  
 
Besides the children with UTI none of the urine dipsticks showed significant proteinuria or 
haematuria. 
 
Table 4.4: Cultured organisms in children with a urinary tract infection (UTI) stratified by simple 
and complex Multicystic Dysplastic Kidney (MCDK) disease 
Organism 
Overall 
n=59 (%) 
Simple 
n=51 (%) 
Complex 
n=8 (%) 
Escherichia coli 8 (13.6) 6 (11.8) 2 (25.0) 
Klebsiella species 2 (3.4) 2 (3.9) 0 
Candida species 1 (1.7) 1 (2.0) 0 
 
4.4  Radiological investigations 
A number of imaging modalities were used to investigate MCDK patients (Table 4.5). 
All patients had abdominal ultrasounds done. Ultrasounds were repeated in some patients up to 
six times. In our 59 patients 58 patients had at least one nuclear scan done. Patients without 
proven non-functional kidney were excluded from our study. A further 20 patients had a second 
scan and four patients had three scans. 
 
VCU is one of the routine investigations done to rule out VUR. In our study, 43 patients had 
VCUs including all eight with complex MCDK patients. None of the patients in our study had 
reflux into the contralateral kidney (see Table.4.3 above). One patient had reflux into the MCDK. 
The radiological investigations done are shown in Table 4.5. 
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Table 4.5: Frequency of radiological investigations of patients stratified by simple and complex 
Multicystic Dysplastic Kidney (MCDK) disease 
Imaging Type 
Overall 
n=59 
Simple 
n=51 
Complex 
n=8 
1
st
 Nuclear Scan 58 50 8 
Mag 3
1
 42 36 6 
DTPA
2
 4 4 0 
DMSA
3
 12 10 2 
    
2
nd
 Nuclear Scan 20 15 5 
Mag 3 9 6 3 
DTPA 4 3 1 
DMSA 7 6 1 
    
3
rd
 Nuclear Scan 4 1 3 
Mag 3 3 0 3 
DMSA 1 1 0 
    
1
st
 VCU
4
 43 35 8 
2
nd
 VCU 3 1 2 
    
1
st
 Ultrasound 58 50 8 
2
nd
 Ultrasound 31 24 7 
3
rd
 Ultrasound 20 13 7 
4
th
 Ultrasound 6 4 2 
5
th
 Ultrasound 3 3 0 
6
th
 Ultrasound 1 1 0 
    
CAT
5 
Scan Abdomen 6 5 1 
MRU
6
 3 2 1 
IVP
7
 6 3 2 
Angiogram 1 1 0 
1
Mag3-Mercaptoacetoacetyltriglycine scan, 
2
DTPA-Diethylenetriaminepentacetate scan, 
3
DMSA-Dimercaptosuccinic Acid scan, 
4
VCU-Voiding Cystourethrogram, 
5
CAT-Computerised 
Axial Tomography, 
6
MRU- Magnetic Resonance Urography, 
7
IVP-Intravenous pyelogram  
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4.5 Renal surgical interventions 
Seven of the patients needed renal surgical intervention. Table 4.6 below shows the procedures 
done and stratifies it according to simple and complex MCDK. The statistical significance was 
not calculated since all correctable surgery was done on complex MCDK and preventative 
surgery on simple MCDK. 
   
Table 4.6: Renal surgery of patients stratified by simple and complex Multicystic Dysplastic 
Kidney (MCDK) disease 
Surgical procedure 
Overall 
n=59 (%) 
Simple 
n=51 (%) 
Complex 
n=8 (%) 
Nephrectomy 3 (5.1) 3 (5.9) 0 
PUJ pyeloplasty 2 (3.4) 0 2 (25.0) 
Nephrectomy & pyeloplasty 1 (1.7) 0 1 (12.5) 
Orchidopexy 1 (1.7) 0 1 (12.5) 
 
4.6 Glomerular filtration rate 
The GFR was calculated using the Schwartz formula (18). The results are shown in Table 4.7 
below. The creatinine is calculated using the modified Jaffe method in our laboratory which uses 
the Roche Cobas® 8000 machine. At the first visit we calculated 41 of the 59 patients GFR. 
Those patients whose creatinine or height/length were not available could not be calculated. Most 
of the patients were very young. At the last visit many patients did not have their bloods done and 
only ten patients could have their GFR calculated. Patients older than two years and those that 
had bloods done before their last visit or before being loss to follow up had their GFR calculated. 
Of our 59 patients 31 were older than two years old and 25 had bloods done to calculate GFR.  
 
Table 4.7: Glomerular filtration rate (GFR) at admission, last visit and last calculable value 
 Number Median GFR 
( ml/min/1.73m
2
) 
Interquartile Range 
( ml/min/1.73m
2
) 
Admission 41 45.4 25.5 to 71.8 
Last visit 10 130.4 108.2 to 164.5 
Last calculable value
1 25 157.0 129.7 to 174.6 
1Last calculable value- GFR of patients older than 2 years with last available creatinine and height 
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4.7 Outcomes 
The outcomes of patients are outlined in Table 4.8 and in Figure 4.2. Of the patients that 
presented to us three were palliated. They were all young patients, two with CKD and one with 
Trisomy 13. Two were complex with a hypoplastic contralateral kidney and had a Potter’s like 
sequence presenting with respiratory distress and both needing ventilation. The simple MCDK 
patient had trisomy 13. Only three (5.1%) over the 30 year period were transferred to adult clinic. 
The majority of patients twenty nine (49.2%) were lost to follow up and twenty four (40.7%) are 
currently being followed up at our follow up clinic. 
 
Duration of follow up days was not significantly different between the simple and complex 
MCDK patients. In fact it was almost identical. The age at last visit was also not statistically 
significant. Simple MCDK 631 days (IQR 218-3555 days) versus complex MCDK 635 days 
(IQR 200 – 3747 days) with a p-value of 0.808.  
 
Table 4.8: Outcomes of patients with simple and complex Multicystic Dysplastic Kidney 
(MCDK) disease 
 
Overall 
n=59 (%) 
Simple 
n=51 (%) 
Complex 
n=8 (%) 
p-value
1
 
Outcome      
Demised 3 (5.1) 1 (2.0) 2 (25.0) 
2 
Lost to follow-up 29 (49.2) 26 (51.0) 3 (37.5) 
Currently follow-up 24 (40.7) 21 (41.2) 3 (37.5) 
Transferred to adult services 3 (5.1) 3 (5.8) 0 
     
Duration of follow-up (days)     
Median (IQR
3
) 631 (147-3037) 631 (147-3073) 582 (185-3736) 0.938 
     
Age at last visit (days)     
Median (IQR) 870 (218-3555) 870 (218-3855) 635 (200-3747) 0.808 
1
p-value - using the chi-squared, Fishers exact or Mann Whitney test, 
2 
the statistical calculation 
was not done due to the extremely small numbers, 
3
IQR-interquartile range 
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Figure 4.2: Flow diagram showing the outcome of patients with MCDK stratified by simple and 
complex MCDK 
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4.8 Changes in antenatal presentation over study period 
An analysis of the patients was done over the three decades, 1986 to 1995, 1996 to 2005 and 
2006 to 2015.See Table 4.9. In terms of the number of patients, of the 59 in this study nine 
(15.25%) were in the first decade, 22 (37.29%) were in the second decade and 28 (47.5%) were 
in the third decade. In the first decade no patients were diagnosed with antenatal ultrasound, 
seven in the second decade and 13 in the third decade. Comparing the first decade and the third 
decade in terms of the number of patients diagnosed with ultrasound there is significant statistical 
difference with a p-value of 0.015.  
 
Table 4.9: Proportion of patients diagnosed on antenatal ultrasound over three decades  
 
1986 to 1995 1996 to 2005 2006 to 2015 p-value
1
 
Number of patients with MCDK 
disease 
n=9 n=22 n=28  
Proportion of patients diagnosed 
by antenatal ultrasound 
0 7 (31.2) 13 (46.4) 0.015 
1
p-value -comparing the 1
st
 and 3
rd
 decade using a Fishers exact test 
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5.0 Discussion  
The number of patients in our series over 30 years was only 59. Separating the patients into three 
separate epochs, of ten years each, demonstrated a progressive increase in our numbers with each 
successive decade (Table 4.9). This was most likely due to the increased use of antenatal 
ultrasound. The most common abnormalities detected by antenatal screening are those of the 
urinary tract (19). The incidence of MCDK is quoted as 1 in 1000 to 1 in 4300 births (1, 4). 
However this figure has never been evaluated in Africa. It is possible that there is a genetic 
variance, and hence a different incidence, in Africa but the statistical difference between the first 
and third decade (p=0.015) indicates that we can expect an increase in the detection number of 
cases of MCDK over the coming years. This follows international trends where more patients are 
being diagnosed on antenatal ultrasound as it became more freely available (6).  In fact MCDK 
has been described as a diagnosis that is increasingly rare in the postnatal period (9). Only 
33.89% of the patients were diagnosed antenatally in our series of patients. The numbers have 
almost doubled in the third decade from the first decade. If this trend continues, even at a 
conservative figure, we should be seeing one MCDK in 4300 live births. Soweto has 
approximately 25 000 births per annum (20) which would translate into 5.8 cases per year i.e. 58 
per decade or 174 in three decades. Of our patients in the clinic 33.9% were referred from outside 
of Soweto, which means we should have at least 263 patients in this series. This demonstrates 
that if we are not prepared for this load of patients in the nephrology department we will be 
swamped with MCDK disease. Internationally there seems to be an increase in MCDK as well as 
other urinary tract abnormalities. This could be attributed to better trained radiologists with more 
sensitive equipment (19). Ylinen and Wikstrom also suggest that diabetic mothers have an 
increased risk of MCDK in their children leading to the increasing incidence of MCDK (21).  
 
The differentiation of patients into simple and complex is important as many authors have shown 
the differences in outcome between the two groups (2, 10, 11). We have also analyzed our data 
showing our patients in these two categories. But the number of patients in the complex MCDK 
was only eight (13.6%) and too small a number to show statistical significance as shown in many 
of the tables in the Results section above. In the study by Hayes et al, they had 14% of their 
patients with contralateral abnormality of the kidney (22). This is similar to our results but our 
numbers are small. In the paper by Psooy it is recommended that patients with simple MCDK 
should be followed by primary health care workers as opposed to those with complex MCDK 
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who should be followed up by specialist clinics (23). In a resource limited setting it is essential to 
rationalize these resources. Feldenberg and Siegel found 40% of their patients to have complex 
MCDK with 50% of the complex MCDK in CRF or ESRD requiring RRT (2). They concluded 
that the prognosis is poorer in complex MCDK. They had only 35 patients of whom 14 were 
complex MCDK, thus the numbers were small making it difficult to interpret or draw definitive 
conclusions. 
 
On literature review the meta-analysis by Schreuder et al best demonstrated the increased number 
of males (59.2%) and left sided MCDK (53.1%) in which 67 cohorts were reviewed (6). Our set 
of patients showed more males (61%) and more left sided kidneys (52.5%) involved. This is in 
keeping with the international trends. Why this is more than the 51% expected in males is not 
clear but consistent in both MCDK and in other renal malformations (6). 
 
The median age of presentation was 19 days which was no different from the literature review.   
Figure 4.1 show that the children born with MCDK grew well. A lot more children caught up 
their growth at their last visit. A possible reason for the increased number of children below the   
-2 SD at first presentation could be due to the fact that majority of the children presented in the 
neonatal period. This study is a retrospective study and it was not possible to determine if the 
patients were premature, small for gestation or both. The patients seem to have caught up growth 
by the time they came to their last visit as seen in Figure 4.1. This shows normal growth of 
children born with MCDK. 
 
The presenting complaints varied. Initial literature showed similar results, however many of these 
centres now have very high percentage of antenatal ultrasound diagnosed MCDK. Unless we 
have a significantly different predisposition in our population we should see an increase in the 
number of patients diagnosed with MCDK.  
  
UTI as a presenting complaint was found in seven patients but confirmed UTI with an organism 
was found in 11 patients at presentation. This difference can be explained by the fact that the 
majority of the patients were neonates (median age of 17 days) and neonates have non-specific 
symptoms and signs because they are immuno-compromised. The organisms grown were 
typically as expected as shown in Table 4.4 (24). 
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Twenty of our patients were referred from hospitals outside of the Soweto region. Since we are a 
tertiary centre this is expected. This does highlight the fact that over a 30 year period we have 
only seen thirty nine patients from Soweto. We saw 29.4% simple MCDK and 62.5% complex 
MCDK patients referred from these hospitals. This was as expected as complex MCDK is more 
complicated (2), however the actual number of complex MCDK were too few to make any 
statistical significance. 
 
In the era when HIV prevalence was very high it is surprising that none of the patients that were 
tested was positive. A large percentage (49.2%) was not tested. 87.5% of the complex MCDK 
tested negative for HIV. Again due to the small numbers it is difficult to evaluate statistically. 
 
The contralateral kidney abnormality was predominantly PUJ obstruction in seven (87.5%) 
patients of which 42.9% needed pyeloplasty. See Table 4.6. One patient had ureteric stricture 
which did not need intervention. Ureteric stricture associated with MCDK has been reported as a 
case study (25). Other studies showed a variety of abnormalities and the most common being 
VUR (6). None of our patients had VUR in the contralateral kidney.   
 
Only four (6.7%) patients had nephrectomies done. There were no patients with malignancies. 
All the nephrectomies were done to avoid any malignancies from developing. Some studies have 
shown that the risk of malignancies is at most equivalent to that of the normal paediatric 
population (23, 26). These studies have concluded there is no real risk for malignant 
transformation. Homsy et al showed two cases of early transformation of MCDK remnant tissue 
to become Wilms Tumour (27). Five other cases have been documented but with questionable 
certainty (10). These two cases are not sufficient to conclude the need for nephrectomy. However 
the review by Truong et al suggest that there is insufficient evidence to link malignancy to 
MCDK (28). Thus there is a need for good transition of patients from paediatric to adult services 
so that this population can be monitored carefully for malignancies in the adult services. 
 
One of the associations with MCDK is undescended testes and it is only beginning to be 
described as an association (5). In our series it is difficult to comment due to our study being a 
retrospective; however we did have one patient who had orchidopexy done. Feldenberg and 
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Siegel also found one patient with undescended testes (2). Carazo-Palacios et al found 10.7% of 
their patients with cryptorchidism (3). Specifically checking for undescended testes should be 
done routinely in all males with MCDK. The Canadian Urology Society now advocates to 
routinely look for anomalies of internal genitalia associated with MCDK (10).  
 
First radiological study on our patients was abdominal sonography. All our patients had at least 
one ultrasound scan and one as many as 6 ultrasound scans. It is an excellent mode to detect 
MCDK, but it is operator and apparatus dependant. In our setting we have a variety of people 
ranging from training radiographers, radiology registrars, fellows in paediatric radiology to 
experienced paediatric radiologists doing ultrasonography. We also have a high turnover of staff 
in our radiology department. Due to these factors the actual diagnosis of MCDK could be missed 
and a confirmatory functional nuclear scan is generally required. Only one patient did not have a 
nuclear scan to confirm a non-functional kidney. This patient had a CAT (Computerised Axial 
Tomography) scan of the abdomen which confirmed a non-functional kidney. A few patients 
were not included in the study because they had nuclear scans that showed function in the kidney 
and hence excluded as MCDK. This is in contrast to the experience of Carazo-Palacios et al 
which showed a 100% positive predictive value of renal ultrasound to diagnose MCDK and 
question the need of  a radio nuclear scan (3). 
 
Routine VCU in MCDK were encouraged by the study done by Zerin and Leiser (29). A number 
of studies have questioned the routine use of VCU in MCDK patients (16, 30). These are in 
centres that have high rates of VUR. VUR is also described as the most common abnormality 
associated with the contralateral kidney in patients with MCDK (31). This is confirmed by the 
meta-analysis done by Schreuder et al showing VUR to be the most common abnormality in 
MCDK at 19.7% (6). The majority of our patients, 43 (72.9%) had a VCU done. In our setting 
not a single patient had reflux into the opposite kidney and only one patient had mild reflux in the 
MCDK. This finding of low rate of reflux is shown to be true in our population in the study by 
Kala and Jacobs (24) in which they looked at reflux in malnourished children at the same 
hospital. Selzman and Elder showed 4% of black patients as opposed to 22% of white patients 
with MCDK had contralateral VUR (32). These studies imply that there might be a genetic 
predisposition in African children to be less likely to have VUR. Hence routine VCU in our 
patients should not be done. The cost effectiveness of this is huge in terms of discomfort, 
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irradiation and finance. This is more so in our resource limited environment. This is in contrast to 
recommendation by Kaneko et al who found VUR the most common contralateral abnormality 
(33) and a VCU was recommended. Kanyema et al did a study in solitary kidneys and came to 
the same conclusion (34). However in the commentary by Friedman, the recommendation is not 
to do routine VCU even in patients that commonly have VUR (35).  
 
A number of patients had a variety of imaging done besides ultrasound (as shown in Table 4.5) 
including CT abdomen, retrograde pyelogram, MRU, IVP and angiogram. Follow up ultrasound 
is important to look for involution and compensatory hypertrophy in the opposite kidney. Our 
study could not define these due to the fact that ultrasound was not repeated at fixed intervals and 
hence difficult to compare. MCDK can involute prenatally in 5% of patients and then at any time 
after birth to many years later (9). It has been shown that the smaller the MCDK (<5 to 6 cm) the 
more likely it will involute (5, 36). Compensatory hypertrophy of the contralateral kidney has 
been surprisingly shown to occur intrauterine and at one, five, ten and fifteen years in 49, 78, 89 
and 95% of patients respectively (5). Cardona-Grau and Kogan came to a conclusion  in their 
study that limited radiological evaluation is preferable and further evaluation should be guided on 
clinical findings of  hypertension, UTI and  palpable mass or on the findings of an abdominal 
sonar (9). The study by Kalisvaart et al shows that even in a well-resourced setting 
ultrasonography is still preferred over MRU (37).  
 
Three patients demised in the early period. One child was diagnosed with trisomy 13 and was 
palliated and demised but the renal function was normal. The other two children had CKD at 
diagnosis in the neonatal period and were palliated because we could not offer renal replacement 
therapy in this early age and both had severe respiratory distress requiring ventilation. One went 
home on oxygen for several months before demising, the other demised at an earlier age. The 
patients had hypoplastic kidneys and demonstrated a Potter’s like sequence in their presentation. 
The lack of resources and poor prognosis in these children precluded them from renal 
replacement therapy. We also struggled to get post mortem due to cultural and religious believes. 
There is very little in the literature on CKD with unilateral MCDK. 
 
At the other extreme we have managed to graduate three patients to adult services. At 5.1% it 
really requires a lot of work to improve. All three patients were from the simple MCDK group, 
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we would have expected that more would have been from the complex MCDK since they have 
poorer outcomes (2). Again, with the small numbers that we have, it is difficult to express the 
statistical significance and analyse it statistically. The largest group of patients were lost to follow 
up (49.2%). In the context of the good outcome of MCDK Mashat et al attributes the lost to 
follow up to the fact that the family are relieved at the good prognosis (38). However this trend of 
high percentage of patients lost to follow up seems to be constant in our population. A research 
project on MCNS showed a rate of 62% (39) and a research on prune belly syndrome showed a 
lost to follow up of 57% (40). Unpublished research by B Sangweni RN showed in the  renal unit 
at Charlotte Maxeke Johannesburg Academic Hospital, one of the three hospitals attached to the 
University of the Witwatersrand, the average spend on transport to health care facilities ranged 
from 4.9 to 27.1% of the families total income depending on whether they did peritoneal or 
haemo-dialysis (41). This also partially explains the poor follow up. It also highlights the 
importance of social services in a setting were the government spends huge amounts on 
management of medical conditions but patients are lost to follow up due to lack of a small 
fraction of the actual spend for transport and social services to follow up and retrieve these 
patients. This emphasises the importance of a multidisciplinary and multi-departmental approach 
to get good outcomes and the prudent use of our limited resources. In the study by Mallik et al 
they had 3.4% of their patients lost to follow up (19). This demonstrates how much can be 
achieved in improving our follow up rate. We had 49.2% of our patients lost to follow up clinic. 
Possibly new strategies to include in their management: increased counselling of patients and 
parents, decreased number of follow up visits per year, and an increased use of social services 
would improve the number of patients being followed up and decrease the number lost to follow 
up clinic. 
 
The median age at last visit is 2.4 years and the median duration of follow up is 1.7 years. This is 
in contrast to the study by the Trent and Anglia MCDK study group where median follow up was 
10.1 years (22).  
 
The figure 4.2 summarises the outcome of our patients. Of note is the fact that the prevalence of 
MCDK of all our renal patients at our clinic over the 30 years is 5.7 per 1000 renal patients 
admitted in CHBAH. This seems to imply that many of our MCDK are missed due to the fact 
that very few patients have antenatal ultrasound.  There is a current drive in the National 
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Department of Health to increase the number of ANC (antenatal) visits among pregnant women. 
This will also translate to increased number of pregnant women getting antenatal ultrasounds in a 
country where antenatal ultrasound are done in few patients as highlighted by Stewart (8). As the 
number of ultrasounds done antenatally increase there will be more patients with MCDK 
diagnosed. Statistical significance of this is shown in our study as seen in Table 4.9.  With this 
increase, our renal services are going to be put under pressure in terms of resources. 
Rationalisation and protocol driven services will help streamline this process. The European renal 
anomaly detection program in which more than 700 000 foetal examinations were done showed 
MCDK in 0.014% of the patients (42). This clearly shows that the number of patients with 
MCDK can be overwhelming. 
 
The eGFR (estimated Glomerular Filtration Rate) using the modified Schwartz formula (18) on 
presentation was low, median of 45.4 ml/min/1.73m
2
 (IQ 25.3 – 71.83 ml/min/1.73m2). This was 
due to the fact that most of the children were neonates. There were a total of 41 patients on whom 
we could calculate eGFR at the first visit. The others did not have eGFR calculated due to 
missing length/height or creatinine at presentation. At the last visit the eGFR was much higher, 
median of 130.4 ml/min/1.73m
2
 (IQR 108.2–164.5 ml/min/1.73m2). In this group only ten 
patients’ eGFR could be calculated primarily due to the fact that they were the only patients on 
whom bloods were taken at the last visit. Two children were less than two years, and the other 
eight were above two years old. The eGFR in these patients showed that three of the ten patients 
have hyperfiltration but all without proteinuria. We further analysed the eGFR of 25 patients. 
They were all above the age of two years and had bloods done. This was out of a group of 31 
patients. The results clearly showed hyperfiltration with a median of 157.0 ml/min/1.73m
2 
(IQR129.7 to 174.6 ml/min/1.73m
2
) all without proteinuria. In the study by Sharada et al they 
showed 29% of their patients had sub-nephrotic proteinuria and all had complete involution of 
the MCDK, proposing that it was all due to hyperfiltration (43). None of our patients had CKD. 
Hayes et al in their study found a median eGFR of 93 ml/min/1.73m
2
 (range 47 – 181 
ml/min/1.73 m
2
) (22). In the same study they found 40 patients with normal eGFR, 33 patients 
were classified as CKD 2 and two patients with eGFR > 160 ml/min/1.73m
2
 without proteinuria. 
This concern is due to Brenner’s hypothesis of hyperfiltration. This is possibly compounded by 
the fact that we also have increasing number of premature births who also have a predisposition 
to decrease in number of glomeruli according to Barker’s hypothesis (44). Mansoor et al also 
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found patients with CKD and proteinuria (45). Hence we need to monitor the eGFR in these 
patients for life. None of our patients had CKD outside of the neonatal period. However our 
eGFR was much higher than other studies (22, 38, 46) and this could point towards a genetic 
predisposition as well as a possible increase risk of CKD/ESRD. This needs more research and 
investigation, but black African paediatric patients in our cohort seem not to have proteinuria. 
  
Of all our patients only three (5.1%) patients were diagnosed with hypertension and were put on 
treatment. Hypertension was found to be very low (5.4 per thousand) in patients with MCDK in 
the study done by Narchi et al as opposed to the normal population rate of 4-5%  (13). This low 
to normal rate was supported by other subsequent studies (2, 5, 47).   
 
No patient was diagnosed with any form of malignancy. This is in keeping with the systemic 
review done by Narchi et al in which none of the 1041 patients reported had Wilms tumour in all 
of the 26 studies that were reviewed (26). Eickmeyer et al also did not find any malignancy in 
300 patients studied over 30 years (5). This has been the reason why paediatric nephrologists 
have opted for conservative treatment and stopped nephrectomies to prevent Wilms tumour or 
other malignancies from the remnants of MCDK. The review by Psooy indicates that there is a 
possibility of renal cell carcinoma in adulthood but further studies are required to prove this 
association  (10).  
 
Proteinuria, CKD, HPT and the possibility of malignancy are factors that may become a problem 
in adulthood. Hence MCKD patients need closer monitoring and better transition to adult 
services. There seem to be very few longitudinal follow up studies out of the paediatric age range 
since single kidney/MCKD patients form a very small percentage of CKD/ESRD in adults (48).  
  
The main limitations of the study were that it was a retrospective review, with a lack of stringent 
protocol for investigations and a very high rate of loss to follow up.   
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6.0 Conclusion 
The demographics of the patients in our study essentially are very similar to other studies done 
worldwide. It should be noted that this is the first description of MCDK from Africa. Over a 
period of 30 years we have had only 59 patients out of 10445 renal patients admitted in our 
nephrology services over this period. This is more likely due to the small percentage of pregnant 
women that are offered antenatal ultrasounds. Our study showed a statistical difference in the 
number of patients diagnosed with MCDK in the first and third decade of the patients reviewed in 
this series. It also showed that the number of children diagnosed increased from nine to 28 in this 
period. This seems to indicate that with increased antenatal diagnosis we should approximate the 
international incidence. However there is a possibility that our population might have a different 
predisposition to MCDK. All studies seem to indicate the incidence to be 1 in 1000 to 1 in 3700 
live births. 
 
Out of 43 children who had VCUs done only one child had reflux and that was into the MCDK.  
The recommendation of decreased number of VCU is in keeping with worldwide 
recommendations (6, 9, 30, 35) and due to our low rate of reflux we can stop routine VCU for 
MCDK. 
 
Although there is a sentiment that it would be safe to diagnose MCDK in most cases without 
nuclear imaging, I strongly recommend that we continue to do nuclear imaging on every MCDK 
patient to confirm diagnosis due to the fact that we do not have a dedicated and experienced 
sonography services and the radio nucleotide demonstrated unequivocally non function in the 
kidney.  
 
The two early deaths from CKD were patients with Potter’s like sequence who had severe 
hypoplastic contralateral kidneys. Post mortem studies would have assisted in the diagnosis but 
that is difficult in our setting due to cultural, belief systems and socio-economic reasons. 
 
An important differentiation to be made in MCDK is to separate them into simple MCDK and 
complex MCDK. In this study the patients were separated into the two groups but there were too 
few cases of complex MCDK and hence very difficult to show any statistical differences. More 
investigations in this area needs to done with larger numbers in a prospective study. 
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The small number of patients being transferred to adult services is worrying since the majority of 
the patients are lost to follow up clinic. This trend needs to be addressed and an attempt has to be 
made to reverse it. Firstly, by intensive counselling and education of the patients and their 
families on presentation by doctors, nursing staff and counsellors. Secondly, the utilisation of 
social workers to contact patients missing their appointments and providing transport to attend 
the clinic. Thirdly, the stream lining of services with an attempt to decrease the number of visits a 
patient has to attend. 
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7.0 Recommendations 
The recommendations emerging from this study are as follows: 
1. VCU should not be done routinely on patients with MCDK, more so in patients of 
Black African descent. 
2. Patients with MCDK should be separated into simple and complex MCDK. The 
simple group does not need to be followed up as closely as the complex group. 
3. All patients with MCDK need to be followed up to monitor for proteinuria, 
hypertension and CRF. 
4. More research needs to be done to monitor patients beyond the paediatric age group to 
monitor if they have a genuine predisposition to malignancies and or CKD. 
5. All our patients need more counselling and social services intervention. 
Recommendations and interventions at provincial and central government needs to be 
advocated for, so as to improve follow up of these and other chronically ill patients. In 
light of the fact that resources are being spent on investigations and management of 
these patients but are lost to follow up due to lack of transport money and poor social 
circumstances. 
6. The utilisation of antenatal sonars should be encouraged to allow for early detection of 
patients with MCDK and other congenital abnormality allowing for early intervention 
and management to improve outcomes. In severe bilateral involvement of the kidneys 
termination of pregnancy can be offered.  
7. The follow up of MCDK should be protocol driven especially as the number being 
diagnosed increases. 
8. Undescended testis need to be checked for in every boy with MCDK.  
9. Utilisation of telephonic reminders for the clinic dates using short message services 
(SMS) to improve attendance at follow up clinic.  
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Appendix   A: Ethics clearance certificate 
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Appendix   B: Data Collection Sheet 
Participant number: 
Gender: 
Date of Birth: 
Date of presentation: Referred from: 
Weight: ____kg 
Height/Length: ____cm 
HIV Status (positive/negative/exposed/unknown): 
Urine dipstick (leucocytes, nitrites, protein, blood): 
UTI (yes/no): 
Organism on UTI: 
Abdominal mass presentation (yes/no): 
Intrauterine ultrasound done (yes/no): 
Systolic BP: _______mmHg Diastolic BP: _______mmHg  
Associated abnormality: 
Blood results (Full Blood Count / Urea, Creatinine and electrolytes 
/Calcium, Phosphate/ HIV):  
      Date: 
 Results: 
 
Follow up:   Date: 
 Weight: _____kg 
 Height/Length: _____cm 
 Blood results (Full Blood Count / Urea, Creatinine and electrolytes / Calcium &      
Phosphate): 
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Imaging:   
               Abdomen ultrasound: Date:  
    Findings: 
 VCU: Date: 
  Findings: 
 Nuclear Scan: Date: 
   Type of Scan: 
   Findings:     
Outcomes: 
Death (yes/no): 
ESRD (yes/no): 
Surgery (yes/no): 
 Details: Type ___  Date ____ 
Transfer to adults (yes/no):  
Lost to follow-up (yes/no):                        Date ______ 
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Appendix   C: Turnitin Report 
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